ELIXIRGEN LLC has a total of 16 patent applications. Its first patent ever was published in 2012. It filed its patents most often in United States, Australia and Japan. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are CURNA INC, COLLARD JOSEPH and OPKO CURNA LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 3 | |
#2 | Australia | 2 | |
#3 | Japan | 2 | |
#4 | Brazil | 1 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | EPO (European Patent Office) | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Mexico | 1 | |
#10 | Singapore | 1 | |
#11 | WIPO (World Intellectual Property Organization) | 1 | |
#12 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Measuring microorganism processes | |
#5 | Medical preparations | |
#6 | Sugars | |
#7 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Ko Minoru S H | 13 |
#2 | Minoru S H Ko | 2 |
#3 | Amano Tomokazu | 2 |
#4 | Hirata Tetsuya | 1 |
#5 | Ko Shigeru B H | 1 |
#6 | Ko Minoru | 1 |
Publication | Filing date | Title |
---|---|---|
JP2018143239A | Methods for efficient differentiation of pluripotent stem cells into desired cell types | |
MX2015012176A | Methods of using zscan4 for rejuvenating human cells. | |
AU2012256014A1 | Use of Zscan4 and Zscan4-dependent genes for direct reprogramming of somatic cells | |
AU2012230894A1 | Compositions and methods for enhancing the pluripotency of stem cells | |
EP2668264A1 | Zscan4 as a marker for pancreatic stem cells and progenitor cells and use thereof |